About Mipharm
Mipharm is a Healthcare company based in Milan (Italy) founded in 1998, and was acquired by Alto Partners in March 2022. CDMO services and drug delivery technologies are provided. Mipharm has completed 1 acquisition, including Alfa Omega. Its chief executive, as recorded, is Pierangelo Costa. Mipharm offers products and services including Pharmaceutical Production, Packaging Services, R&D Services, and Logistics Services. Its focus areas include Life Sciences, Drug Delivery and Diversified. Its legal entity is Mipharm Spa.
Company details
Mipharm is a CDMO also develops drug delivery technologies. It offers third-party manufacturing for oral solid forms, solutions, suppositories, packaging, nasal spray solutions, oral potent drugs, sachet, creams. It also offers services such as new product development, QCQA services, and clinical trials (logistic) management. It has also developed new formulation based on breakthrough technology, Miphargel, providing a vaginal delivery system and Moussina Technology, a non-aerosol foam.
- Headquarters Milan, Italy
- Stage Acquired
- SectorsHealthcare
- Phone•••• ••••
- Website mipharm.it
- Social LinkedIn X YouTube
- Acquired by Mandarin Capital Partners (Dec 2016)
- Legal Name Mipharm Spa
- InvestorsAlto Partners
& 2 more
- Investments & Acquisitions
- Acquired by
Products & Services of Mipharm
Mipharm offers a comprehensive portfolio of products and services, including Pharmaceutical Production, Packaging Services, R&D Services, and Logistics Services.
Production of innovative drugs and solutions for pharmaceuticals
Secure packaging for pharmaceutical products and safety
Research and development for new pharmaceutical innovations
Logistics management for clinical trials and distribution
Apps and channels of Mipharm
its YouTube channel Mipharm has 18 subscribers.
Funding Insights of Mipharm
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Mipharm with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2016 | Seed | – | – |
3 investors in total: 3 institutional.
Investors in Mipharm
Mipharm has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Alto Partners, Mandarin Capital Partners and Mindful Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| altopartners.it | ||||
| mcpinvest.com | ||||
| mcpinvest.lu |
Investor details for Mipharm
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Mipharm
7 people are tracked at Mipharm (4 in leadership, 3 in team).
| Name | Role | Group |
|---|---|---|
Pierangelo Costa | CEO | Leadership |
Egidio D'Amelia | Quality Systems Head | Leadership |
Maurizio Silvestri | President And CEO | Leadership |
Camillo Bologna | Quality Unit Director And Qualified Person | Leadership |
Rosa Terribile | QA Manager | Team |
Davide Pavanelli | Quality Control Manager | Team |
Marina Garlati | QA Assistant | Team |
Complete people profiles for Mipharm
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Mipharm
Mipharm has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Alfa Omega.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
CDMO services for probiotics manufacturing and regulatory assistance are provided. | alfaomega.it | Copparo, Italy | 1985 | Mar 2023 | •••• |
Complete acquisition details for Mipharm
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Mipharm
5 dated milestones of Mipharm across 25 years, from founding to its latest funding, stage changes and deals.
- Founded Mipharm is founded.
- Funding First funding round.
- Exit Acquired by Mandarin Capital Partners.
- Exit Acquired by Alto Partners.
- Acquisition Acquires Alfa Omega.
Web traffic of Mipharm
The website of Mipharm (mipharm.it) receives about 1.7K visits a month.
- Monthly visits1.7K
▲ 81.4% vs previous month
Websites whose visitors overlap most with Mipharm. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| advicepharma.com | 100% | 1.2K | #10,282,879 | View details | |
| novacell.com | 94% | 1.9K | #8,657,904 | View details | |
krka.it | krka.it | 92% | #8,562,208 | – | |
qualityassurance.it | qualityassurance.it | 92% | #4,958,845 | – | |
| trifarma.it | 91% | 1.9K | #10,288,949 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 8 similar websites and full traffic analytics for Mipharm
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 8 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Mipharm
Complete news archive for Mipharm
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mipharm
Mipharm was founded in 1998 and raised its 1st funding round 18 years after it was founded.
Mipharm is headquartered in Milan, Italy. It is registered at Milan, Lombardy, Italy.
Pierangelo Costa is the CEO of Mipharm, as recorded in our data.
Mipharm is a CDMO also develops drug delivery technologies. It offers third-party manufacturing for oral solid forms, solutions, suppositories, packaging, nasal spray solutions, oral potent drugs, sachet, creams. It also offers services such as new product development, QCQA services, and clinical trials (logistic) management. It has also developed new formulation based on breakthrough technology, Miphargel, providing a vaginal delivery system and Moussina Technology, a non-aerosol foam.
Mipharm offers Pharmaceutical Production, Packaging Services, R&D Services, and Logistics Services.
Mipharm has made 1 acquisition, including Alfa Omega.
Mipharm has 3 investors. Key investors include Alto Partners, Mandarin Capital Partners, and Mindful Capital Partners.
Mipharm operates through Mipharm Spa.
Yes. Mipharm was acquired by Mandarin Capital Partners in December 2016.